As a receptor, VISTA’s inhibitory role on T cell functions was identified for the first time in a study on experimental autoimmune encephalomyelitis (EAE) as a mouse model for multiple sclerosis (MS), where its blockade led to the activation of T cell-mediated immunity and loss of peripheral tolerance [13]. Here, VSIR is linked to myeloid sarcoma.